# Glioblastoma trials recruiting, no drug phase: 88 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 88 trials with no drug phase for glioblastoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting glioblastoma trials with no drug phase: 88 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/glioblastoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 88
- Recruiting or not yet: 88
- Read on: November 19, 2026

## Trials

The 25 newest of 88, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 12, 2026 | NCT07932405 | Adaptive Radiotherapy for Patients With GBM | Abramson Cancer Center at Penn Medicine | Not applicable | Not yet recruiting | Glioblastoma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07932405) |
| October 9, 2026 | NCT07867886 | An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM | Boston Scientific Corporation | Not applicable | Not yet recruiting | Recurrent Glioblastoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867886) |
| October 1, 2026 | NCT07852975 | GLAD-KE GLioma Biomarker and Safety Assessment During Dietary Ketone Elevation Subtitle: A Surgical Biomarker Discovery Study of Ketogenic... | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Not applicable | Not yet recruiting | Recurrent Glioma (Glioblastoma Multiforme) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852975) |
| September 21, 2026 | NCT07831772 | REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma | University of Minnesota | Not applicable | Recruiting | Glioblastoma, Newly Diagnosed Glioblastoma, Brain Tumor | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831772) |
| September 21, 2026 | NCT07831161 | Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma | Dong-A University Hospital | Not applicable | Not yet recruiting | Recurrent Glioblastoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07831161) |
| August 26, 2026 | NCT07788430 | Impact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical Study | Institut Claudius Regaud | Not applicable | Not yet recruiting | Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07788430) |
| August 20, 2026 | NCT07775534 | Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma Patients | City of Hope Medical Center | Not applicable | Recruiting | Glioblastoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775534) |
| August 18, 2026 | NCT07769918 | Hypoxia-targeted Radiotherapy Boost for GBM | NYU Langone Health | Not applicable | Not yet recruiting | Glioblastoma (GBM) | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07769918) |
| July 28, 2026 | NCT07731555 | Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological... | Sponsor not shown (see the record) | Not applicable | Recruiting | Glioblastoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731555) |
| July 8, 2026 | NCT07689721 | ctDNA-Guided Intraventricular Therapy for CNS Malignancies | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Leptomeningeal Disease, Glioblastoma, Brain Metastases, Non-Small Cell Lung Cancer, Breast Cancer | 77 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07689721) |
| July 1, 2026 | NCT07678138 | Exploratory Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Tumor Neoantigen-pulsed Autologous Dendritic... | Huanhu Hospital Affiliated to Tianjin Medical University | Not applicable | Not yet recruiting | Glioblastoma | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07678138) |
| June 26, 2026 | NCT07670455 | Brain Radiotherapy Imaging for High-grade Glioma Using Hypoxia Targeting Through Oxygen-Enhanced Response | The Leeds Teaching Hospitals NHS Trust | Not applicable | Recruiting | High Grade Gliomas, Hypoxia Brain, Glioblastoma (GBM), Brain Neoplasms, Adult | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07670455) |
| June 25, 2026 | NCT07668869 | TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0) | Sponsor not shown (see the record) | Not applicable | Recruiting | Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Glioblastoma Multiforme, Adult | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668869) |
| June 9, 2026 | NCT07636200 | The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer | University of Colorado, Boulder | Not applicable | Recruiting | Advanced Solid Tumor Cancer, Stage IV Cancer (Solid Tumors Only), Glioblastoma, Stage III Ovarian Cancer, Small Cell... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636200) |
| June 5, 2026 | NCT07628647 | Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being | University of Colorado, Denver | Not applicable | Recruiting | Brain Cancer | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628647) |
| June 4, 2026 | NCT07628257 | Cerebral Connectivity and Metabolic Phenotype of Gliomas: Prospective Addition of DTI and Rs-fMRI to a Preoperative FDG PET Strategy, With... | Centre Paul Strauss | Not applicable | Not yet recruiting | Glioblastoma | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628257) |
| June 4, 2026 | NCT07627334 | Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled... | Medical University of Vienna | Not applicable | Recruiting | Glioblastoma (GBM) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07627334) |
| June 1, 2026 | NCT07616986 | LITT for Ultra-early GBM Recurrence | Insel Gruppe AG, University Hospital Bern | Not applicable | Recruiting | Glioblastoma (GBM), Glioblastoma - Category | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07616986) |
| May 15, 2026 | NCT07590726 | PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors | Copenhagen University Hospital, Rigshospitalet | Not applicable | Not yet recruiting | Brain Injuries, Acute, Brain Tumor Adult, Brain (Nervous System) Cancers, Traumatic Brain Injuries, Glioblastom WHO... | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07590726) |
| April 27, 2026 | NCT07552233 | NK Cell Therapy for Malignant Solid Brain Tumors | Peking University Third Hospital | Not applicable | Recruiting | Malignant Solid Brain Tumors, Glioblastoma (GBM), Glioblastoma Multiforme (GBM), Brain Metastasis, Malignant Meningioma | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07552233) |
| April 6, 2026 | NCT07512154 | Precision Radiotherapy Enabled by Molecular MRI | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Not applicable | Recruiting | Brain Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07512154) |
| March 25, 2026 | NCT07492836 | Hypofractionated Radiotherapy Plus Temozolamide in Patients Younger Than 70 Years With Glioblastoma | Hospital do Coracao | Not applicable | Not yet recruiting | Glioblastoma (GBM) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07492836) |
| March 23, 2026 | NCT07488754 | Local, Targeted Therapy With Alpha Emitter \[225Ac\]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4) | Medical University of Warsaw | Not applicable | Recruiting | Glioblastoma, High-Grade Glioma (WHO III-IV), Glioblastoma (GBM) | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07488754) |
| March 16, 2026 | NCT07472387 | Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas | Assistance Publique - Hôpitaux de Paris | Not applicable | Not yet recruiting | Glioblastoma (GBM) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07472387) |
| March 9, 2026 | NCT07459101 | UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-4 | Sunnybrook Health Sciences Centre | Not applicable | Recruiting | Glioblastoma (GBM), Astrocytoma, Grade IV | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07459101) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Mayo Clinic | 4 |
| Medical University of Warsaw | 3 |
| Erasmus Medical Center | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 |
| Hospices Civils de Lyon | 2 |
| Shengjing Hospital | 2 |
| Centre Hospitalier Universitaire, Amiens | 2 |
| Medical University of Vienna | 2 |
| Peking University Third Hospital | 2 |
| First Affiliated Hospital, Sun Yat-Sen University | 2 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| Institut Claudius Regaud | 2 |
| Copenhagen University Hospital, Rigshospitalet | 2 |
| Northwell Health | 2 |
| Abramson Cancer Center at Penn Medicine | 2 |
| [Boston Scientific Corporation](https://specstream.ai/data/clinical-trials/company/boston-scientific-corporation) | 1 |
| The First Hospital of Jilin University | 1 |
| Hospital do Coracao | 1 |
| Amsterdam UMC, location VUmc | 1 |
| The Christie NHS Foundation Trust | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Poznan University of Medical Sciences | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 26 |
| France | 13 |
| Netherlands | 7 |
| China | 7 |
| Poland | 6 |
| Germany | 4 |
| Italy | 4 |
| Belgium | 4 |
| Switzerland | 3 |
| Denmark | 3 |
| United Kingdom | 2 |
| Austria | 2 |
| Canada | 2 |
| Ireland | 2 |
| Spain | 1 |
| South Korea | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B oil and gas exploration and development companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-exploration-and-development-companies/united-states)
- [Playground equipment suppliers in the United States](https://specstream.ai/data/businesses/playground-equipment-suppliers/united-states)
- [Excavation contractors in the United States](https://specstream.ai/data/businesses/excavation-contractors/united-states)
- [Wind energy companies in the United States](https://specstream.ai/data/businesses/wind-energy-companies/united-states)
- [Mobility equipment companies in the United States](https://specstream.ai/data/businesses/mobility-equipment-companies/united-states)
- [Courier and delivery companies in the United States](https://specstream.ai/data/businesses/courier-and-delivery-companies/united-states)
